eVOLVE-Meso: A global phase 3 study of first-line volrustomig plus chemotherapy in unresectable pleural mesothelioma Meeting Abstract
| Authors: | Scherpereel, A.; Fennell, D. A.; Fujimoto, N.; Marmarelis, M. E.; Tsao, A.; Aerts, J.; Li, X.; Dalvi, T.; Jiang, H.; Krug, L.; Zauderer, M. |
| Abstract Title: | eVOLVE-Meso: A global phase 3 study of first-line volrustomig plus chemotherapy in unresectable pleural mesothelioma |
| Meeting Title: | 2024 World Conference on Lung Cancer |
| Keywords: | immunotherapy; pleural mesothelioma; bispecific antibody |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 19 |
| Issue: | 10 Suppl. |
| Meeting Dates: | 2024 Sep 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2024-10-01 |
| Start Page: | S281 |
| Language: | English |
| ACCESSION: | WOS:001337925602005 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2024.09.506 |
| Notes: | Meeting Abstract: P2.14B.05 -- Source: Wos |
